Cancer Currents: An NCI Cancer Research Blog
A blog featuring news and research updates from the National Cancer Institute.
-
At the recent annual Conference on Retroviruses and Opportunistic Infections, several NCI researchers and NCI-funded investigators presented important new findings on HIV-related cancers.
-
The FDA has approved lenvatinib (Lenvima) to treat some patients with the most common type of thyroid cancer.
-
Researchers have identified genetic variations in children with brain cancer that increased their risk of rapid hearing loss after treatment.
-
NCI is constantly publishing new information on its websites, so periodically we provide updates on new content of interest to the cancer community.
-
NCI's Dr. Mark Gilbert discusses new developments in neuro-oncology and the priorities of the Neuro-Oncology Branch.
-
Second-hand smoke exposure has fallen by 50 percent since 1999, a new study finds, but millions are still routinely exposed to secondhand smoke.
-
Palbociclib (Ibrance) is approved to be used in combination with letrozole (Femara) to treat postmenopausal women with metastatic breast cancer.
-
For the first time, Medicare will cover the costs of lung cancer screening for some beneficiaries, the Centers for Medicare and Medicaid Services (CMS) announced on February 5.
-
Researchers have surveyed the genetic changes in nearly 300 head and neck cancers, revealing some previously unknown alterations that may play a role in the disease, including in patients whose cancer is associated with the human papillomavirus (HPV).
-
Under the Precision Medicine Initiative, NCI is working to accelerate the pace of research that will help identify which treatments work best for which patients.